stella
beta
Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors — Stella
Recruiting
Back to BRCA1 Mutation trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
University of California, San Francisco, San Francisco, California
View full record on ClinicalTrials.gov